1. Introduction {#sec1}
===============

Because of the influence and limitations of various clinical factors, postoperative AL in rectal cancer is one of the more serious and common complications of rectal cancer. With the development of clinical technology as well as innovations of science and technology, the incidence of AL has decreased; however, worldwide, the incidence of postoperative AL remains at 0--36% \[[@B1]--[@B4]\]. If this complication occurs, the perioperative mortality rate due to this complication is about 5%--20% \[[@B4]--[@B7]\]. In addition, rectal AL can lead to prolonged hospitalization, increased costs of medical care, and substantial pain in patients. In particular, postoperative AL delays the optimal chemotherapy period, even leading to unsuccessful chemotherapy treatment after surgery, creating risk of recurrence or metastasis \[[@B8], [@B9]\]. However, in clinical work, surgeons can only judge whether there is AL, but the occurrence of AL cannot be accurately predicted during the perioperative period, so as to take intervention as soon as possible. There are many factors leading to AL in rectal cancer \[[@B9], [@B10]\], many of which have been clinically confirmed. However, whether nutritional indicators have an effect on AL remains controversial. At present, there are few studies regarding AL and its relation with factors; not only that, there are few clinical guidelines explaining perioperative clinical management and intervention methods for rectal cancer patients with poor nutritional status. Therefore, the purpose of this study was to explore whether perioperative period nutritional indicators and nutritional status of patients had an effect on postoperative AL in rectal cancer and its possible causes.

2. Aims and Methods {#sec2}
===================

This study was a retrospective, observational, single-center study of the effect of perioperative nutritional indicators on the incidence of postoperative AL in patients with rectal cancer. The main purpose was to confirm whether various preoperative, intraoperative, and postoperative nutritional indicators and other related factors affect postoperative AL of patients with rectal cancer.

We collected clinical data from 382 patients with rectal cancer who underwent surgery between September 2015 and May 2017. The inclusion criteria were (1) primary rectal malignant tumor without metastasis or resectable metastasis; (2) the tumor distance to the anus is ≤15 cm; (3) tumor resection and intestinal anastomosis were performed at the same stage; and (4) the patients can defecate independently before operation and there is no complete intestinal obstruction. The exclusion criteria were (1) the patient underwent emergency surgery; (2) the patient received neoadjuvant radiotherapy before operation; (3) patients have a preventive stoma due to poor bowel preparation during surgery; and (4) age is less than 18 years old or older than 85 years old. The 382 patients enrolled were strictly followed up for various indicators and anastomotic healing from the day after surgery. According to the definition of AL in the surgical infection research group in the United Kingdom in 1991 \[[@B11]\], the following conditions suggested AL: (1) the presence of AL confirmed by imaging, (2) clinical observation of intestinal content exudation in drainage tube, (3) confirmation of endoscopic or digital rectal examination, and (4) AL confirmed by emergency surgery.

Excluding some incomplete information or lost follow-up data, the final data of 382 patients were completely collected, including some nutritional indicators before and after surgery and potential risk factors for AL. Nutritional indicators included BMI, NRS-2002 score, PG-SGA score, albumin, and hemoglobin levels before and 4 days after surgery. Common factors include age, history of smoking or drinking, diabetes, hypertension, coronary artery disease, and TNM staging of tumors (AJCC 8th Edition). Perioperative factors included preoperative bowel preparation, incomplete intestinal obstruction, perioperative blood transfusion, surgical approach, postoperative diarrhea, ASA score, and neoadjuvant chemotherapy. The patients were followed up for 1 month after the surgery day, following up the patients or their families by mobile phone and using the data of outpatient system to access whether these patients have tumor recurrence.

The final collected clinical data were analyzed by statistical software SPSS 18.0 (SPSS, Chicago, IL, USA). The counting data and grade data were analyzed by Pearson chi-square test, and the measurement data were analyzed by independent sample *t*-test or nonparametric rank sum test. Further, the statistically significant factors were analyzed by logistic regression. Kaplan-Meier curve was drawn to analyze the recurrence and prognosis of the patients and the definition *p* \< 0.2 was statistically significant.

3. Results {#sec3}
==========

After meeting the inclusion and exclusion criteria, a total of 382 cases of data were included in the study. From [Table 1](#tab1){ref-type="table"}, we can see that 56 patients had AL, accounting for 14.65% of the total number of cases. Among them, 36 were female patients and 20 were male. There were no significant differences in terms of age, height, weight, or BMI.

In the univariate analysis ([Table 2](#tab2){ref-type="table"}), the following factors were found to be associated with AL: high score on NRS-2002, high score on PG-SGA, diabetes, perioperative blood transfusion, postoperative diarrhea, later tumor stage, surgical approach, and ASA score. In [Table 3](#tab3){ref-type="table"}, we can also conclude that rectal cancer patients with tumors closer to the anus are more likely to have AL.

As described in [Table 4](#tab4){ref-type="table"}, statistically significant factors were brought into logistic regression model for multivariate analysis. Multivariate regression analysis showed that postoperative low albumin (*p* = 0.044), tumor close to the anus (*p* = 0.004), diabetes (*p* = 0.003), perioperative blood transfusion (*p* \< 0.001), diarrhea (*p* = 0.005), later tumor stage, and high PG-SGA score (*p* \< 0.001) were independent risk factors for AL after rectal cancer surgery.

Patients with complete intestinal obstruction are unable to make effective intestinal preparation, and patients who have received neoadjuvant radiotherapy did not join this study, because it is clear that the these factors will lead to AL. Prophylactic colostomy is usually chosen to ensure the safety of patients. Adding these data may lead to biased results. Analyzing from the results, neoadjuvant chemotherapy cannot increase the probability of AL, but the later tumor stage can increase the probability of AL. It may be due to the increase of the size of the tumor, which increases the difficulty of the operation, or the edema of the intestinal tract which leads to the poor healing condition of the anastomosis. In [Figure 1](#fig1){ref-type="fig"}, we can get that DFS in the AL group is different from that in the non-AL group, suggesting that the patients in the AL group are more likely to have recurrence after operation which the prognosis is poor. It is also consistent with the previous research results.

4. Discussion {#sec4}
=============

In recent years, due to the development of imaging techniques such as CT and MRI, increasing numbers of asymptomatic or tiny AL have been discovered, making percutaneous drainage more common; advances in antibiotics have made common symptoms such as fever, tachycardia, and increase of infection index caused by AL to be no longer an important indication of reoperation. The most effective treatment in clinical practice is to choose surgical treatment such as enterostomy \[[@B23]--[@B25]\]. While there have been continuous improvements in examination methods, the incidence of postoperative AL in rectal cancer remains high in many large-sample studies, with fluctuations between 3% and 15.9% \[[@B12]--[@B14]\]. The incidence of AL in the rectum is higher, and the results of this study are also within this scope. Nevertheless, this study showed that the incidence of postoperative AL in rectal cancer patients with poor nutritional status remains high. This situation needs our more attention. Statistical analysis revealed a variety of factors, including low postoperative albumin, tumor close to the anus, diabetes, perioperative blood transfusion, diarrhea, later tumor stage, and high score of PG-SGA, which can lead to AL; these factors in the previous literature have also been confirmed. In addition, the study also found that in patients with incomplete intestinal obstruction, if there is adequate intestinal preparation, the incidence of anastomosis leakage does not seem to increase; neoadjuvant chemotherapy will not increase the incidence of AL as well. Unfortunately, due to sample size and single-center limitations, we can only find three independent risk factors related to nutritional status and AL in multivariate analysis. However, diabetes, high PG-SGA score, and low postoperative albumin are an imbalance of nutritional status. Therefore, nutritional assessment and replenishment of perioperative period patients are particularly important.

The nutritional status of patients with rectal cancer is an important factor leading to AL. It is also one of the hotspots for studying AL. A series of studies have reported associations of low-level serum albumin or low-level total protein with postoperative AL in rectal cancer \[[@B15]--[@B18]\]. Several studies have also shown that nutritional support for preoperative malnutrition patients reduced the incidence of AL and other complications \[[@B19], [@B20]\]. Therefore, nutritional support is recommended for patients with poor nutritional status prior to surgery. These nutritional supports are based on enteral nutrition, in order to reduce AL and other complications.

If postoperative AL occurs after surgery, early intervention is the guarantee for reducing mortality. Evidence for the diagnosis of AL after rectal cancer currently includes imaging examination, clinical presentations, and blood routine and biochemical examination. Imaging and clinical manifestations always tend to be lagging indicators. Recent studies have shown that CRP (C-reactive protein) and PCT (procalcitonin) are reliable biomarkers for early detection of AL \[[@B21]\]. It remains a question whether PG-SGA scores, diabetes, and other nutritional indicators can be used as predictors of AL. Although there remains controversy, we believe that early assessment of the nutrition and early intervention for patients with poor nutritional status will reduce the occurrence of AL. At present, intraoperative preventive measures based on patients with high risk of AL are also under study, and great results have been achieved; these include placing a polyurethane vacuum sponge at the anastomosis or blocking drainage on the anastomosis \[[@B26], [@B27]\], effectively reducing the incidence of AL. Some reasonable clinical strategies can be selected according to the nutritional status of the patient, including increasing abdominal drainage or preventive ostomy \[[@B22]\]. In previous studies, many significant factors, such as AL, were more common in men than in women. But the present study is limited by small sample size, in a single center, with statistical bias and some other aspects. Large-scale, multicenter clinical research is still needed. However, we believe that, with the continuous improvement of surgical techniques and assistive technologies, the incidence of AL will gradually decrease and the number of reoperations due to AL will decline. More importantly, the prognosis of these patients will be improved.
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###### 

Analysis of basic clinical information and AL in patients.

  Parameters    Anastomotic leak   *p*                     
  ------------- ------------------ --------------- ------- -------
  Sex           Male               199             36      0.645
  Female        127                20                      
  Age           60.92 ± 10.68      60.59 ± 8.47    0.796   
  Weight (kg)   64.97 ± 11.15      65.34 ± 12.47   0.820   
  Height (m)    1.66 ± 0.77        1.68 ± 0.76     0.122   
  BMI           23.39 ± 3.14       23.03 ± 3.56    0.444   

###### 

Single factor analysis of postoperative AL and clinical parameters of patients.

  Parameters                          Anastomotic leak   *p*        
  ----------------------------------- ------------------ ----- ---- ---------
  NRS-2002                            \<3                301   40   \<0.001
  ≥3                                  25                 16         
  PG-SGA                              0-3                254   6    \<0.001
  4-8                                 71                 37         
  \>8                                 1                  13         
  History of smoking                  No                 258   40   0.198
  Yes                                 68                 16         
  History of alcohol drinking         No                 279   46   0.504
  Yes                                 47                 10         
  Hypertension                        No                 247   45   0.455
  Yes                                 79                 11         
  Coronary heart disease              No                 287   48   0.625
  Yes                                 39                 8          
  Diabetes                            No                 293   32   \<0.001
  Yes                                 33                 24         
  History of abdominal surgery        No                 275   50   0.305
  Yes                                 51                 6          
  Gut preparation                     Traditional        93    16   0.274
  Laxative                            189                28         
  Both                                44                 12         
  Incomplete intestinal obstruction   No                 310   52   0.488
  Yes                                 16                 4          
  Perioperative blood transfusion     No                 322   36   \<0.001
  Yes                                 4                  20         
  Diarrhea                            No                 273   17   \<0.001
  Yes                                 53                 39         
  T stage                             1                  10    0    \<0.001
  2                                   85                 1          
  3                                   154                30         
  4                                   77                 25         
  N stage                             0                  195   19   \<0.001
  1                                   68                 15         
  2                                   63                 22         
  M stage                             0                  294   25   \<0.001
  1                                   32                 31         
  AJCC                                1                  78    6    \<0.001
  2                                   116                12         
  3                                   105                20         
  4                                   27                 18         
  Surgical approach                   Laparoscopic       57    15   0.096
  Open                                265                39         
  Transfer to laparotomy              4                  2          
  ASA score                           1                  92    5    0.003
  2                                   195                38         
  3                                   39                 13         
  Neoadjuvant therapy                 No                 314   55   0.522
  Yes                                 12                 1          

###### 

Single factor analysis of postoperative AL and clinical parameters of patients.

  Parameters                             Anastomotic leak (*x* + *s*)   *p*               
  -------------------------------------- ------------------------------ ----------------- ---------
  Preoperative albumin (g/l)             39.425 ± 3.611                 39.016 ± 3.588    0.434
  Postoperative albumin (g/l)            31.198 ± 4.252                 29.907 ± 5.478    0.046
  Preoperative prealbumin (mg/dl)        21.264 ± 5.605                 21.941 ± 5.967    0.409
  Postoperative prealbumin (mg/dl)       13.907 ± 4.696                 13.202 ± 4.670    0.300
  Preoperative total albumin (g/l)       65.50 ± 5.105                  65.34 ± 4.738     0.826
  Postoperative total albumin (g/l)      54.631 ± 6.367                 53.704 ± 8.342    0.338
  Preoperative hemoglobin (g/l)          134.16 ± 18.601                132.11 ± 20.567   0.453
  Postoperative hemoglobin (g/l)         119.38 ± 16.154                118.11 ± 16.200   0.586
  Tumor distance from anal margin (cm)   9.184 ± 3.259                  7.589 ± 1.727     \<0.001

###### 

Multivariate logistic regression analysis of related factors of AL.

  Parameter                         95% CI   OR        *p*      
  --------------------------------- -------- --------- -------- ---------
  Postoperative albumin             1.004    1.287     1.137    0.044
  Tumor distance from anal margin   0.535    0.886     0.689    0.004
  Diabetes                          2.063    30.322    7.909    0.003
  Perioperative blood transfusion   7.478    436.609   57.139   \<0.001
  Diarrhea                          1.639    16.099    5.136    0.005
  T stage                           1.983    14.663    5.392    0.001
  M stage                           3.141    34.088    10.348   \<0.001
  PG-SGA                            6.541    80.792    22.988   \<0.001
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